Detalhe da pesquisa
1.
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients.
Breast Cancer Res Treat
; 136(3): 659-71, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065032
2.
Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants.
Front Immunol
; 9: 2531, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30450100
3.
Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release.
Front Immunol
; 8: 1342, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29109725
4.
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients.
Innate Immun
; 19(1): 76-85, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22781631